Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling - A pilot study.

Oral squamous cell carcinomas (OSCCs) often present as advanced tumours requiring aggressive local and regional therapy and result in significant functional impairment. The objective is to develop pre-symptomatic screening detection of OSCC by a brush biopsy method which is less invasive than the co...

Descripción completa

Detalles Bibliográficos
Publicado en:Oral Oncology Vol. 47; no. 4; pp. 278 - 282
Autores principales: Remmerbach TW, Maurer K, Janke S, Schellenberger W, Eschrich K, Bertolini J, Hofmann H, Rupf S
Formato: research Journal Article
Publicado: Pergamon Press - An Imprint of Elsevier Science Apr2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104854953&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104854953
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        13688375
        JRJ
      jtl: Oral Oncology
      issn: 13688375
      maglogo: N
    pubinfo:
      dt: Apr2011
      vid: 47
      iid: 4
      pid: 2410
      pub: Pergamon Press - An Imprint of Elsevier Science
    artinfo:
      ui:
        104854953
        104854953
        2010990884
        10.1016/j.oraloncology.2011.02.005
        NLM21354855
        104854953
      ppf: 278
      ppct: 4
      formats:
      tig:
        atl: Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling - A pilot study.
      aug:
        au:
          Remmerbach TW
          Maurer K
          Janke S
          Schellenberger W
          Eschrich K
          Bertolini J
          Hofmann H
          Rupf S
        affil: Department of Oral & Maxillofacial and Facial Plastic Surgery, University of Leipzig, Leipzig, Germany; Griffith Health Institute, Gold Coast campus, Griffith University, QLD 4222, Australia.
      sug:
        subj:
          Carcinoma, Squamous Cell Pathology
          Early Detection of Cancer Methods
          Head and Neck Neoplasms Pathology
          Proteomics Methods
          Mass Spectrometry Methods
          Adult
          Aged
          Aged, 80 and Over
          Algorithms
          Biopsy Methods
          Female
          Gene Expression Profiling Methods
          Male
          Health Screening
          Middle Age
          Pilot Studies
          Proteomics Equipment and Supplies
          Sensitivity and Specificity
          Mass Spectrometry Equipment and Supplies
          Adult: 19-44 years
          Aged: 65+ years
          Aged, 80 & over
          Middle Aged: 45-64 years
          Female
          Male
      ab: Oral squamous cell carcinomas (OSCCs) often present as advanced tumours requiring aggressive local and regional therapy and result in significant functional impairment. The objective is to develop pre-symptomatic screening detection of OSCC by a brush biopsy method which is less invasive than the conventional biopsy for histology. Given the molecular heterogeneity of oral cancer, it is unlikely that even a panel of tumour markers would provide accurate diagnosis. Therefore, approaches such as the matrix-assisted-laser-desorption/ionisation-time-of-flight-mass -spectrometry (MALDI-TOF-MS) allow several biomarkers or peptide profile patterns to be simultaneously assessed. Brush biopsies from 27 patients with histology-proven OSCCs plus 40 biopsies from 10 healthy controls were collected. MALDI-TOF-MS profiling was performed and additional statistical analysis of the data was used to classify the disease status according to the biological behaviour of the lesion. For classification a support vector machine algorithm was trained using spectra of brush biopsy samples to distinguish healthy control patients from patients with histology-proven OSCC. MALDI-TOF-MS was able to distinguish between healthy patients and OSCC patients with a sensitivity of 100% and specificity of 93%. In summary, MALDI-TOF-MS in combination with sophisticated bioinformatic methods can distinguish OSCC patients from non-cancer controls with excellent sensitivity and specificity. Further improvement and validation of this approach is necessary to determine its feasibility to assist the pre-symptomatic detection of head and neck cancer screening in routine daily practice.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N